{'fraction_non_alphanumeric': 0.021645021645021644, 'fraction_numerical': 0.005772005772005772, 'mean_word_length': 6.229166666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Smoking Cessation Pharmacotherapy Among Smokers Hospitalized for Coronary Heart Disease

HEALTH CARE REFORM Smoking Cessation Pharmacotherapy Among Smokers Hospitalized for Coronary Heart Disease Meta-analyses demonstrate that, compared with no treatment, inpatient smoking cessation pharmacotherapy (SCP) coupled with outpatient follow-up significantly improves quit rates.1 Accordingly, the Joint Commission now considers inpatient use and discharge prescription of SCP as the standard of care.2 Despite the potential benefits of initiating SCP in the hospital,3,4 little is known about its use nationwide, and no estimates exist among patients hospitalized for coronary heart disease (CHD).